2-Oxo-2H-Pyrimido[2,1-b]Benzothiazoles Inhibit Brain Benzodiazepine Receptor Binding in vitro
- 1 May 2000
- journal article
- research article
- Published by S. Karger AG in Pharmacology
- Vol. 60 (4) , 175-178
- https://doi.org/10.1159/000028366
Abstract
2-Oxo-2H-pyrimido[2,1-b]benzothiazole derivatives were found to inhibit the in vitro binding of 3H-Ro 15-1788 (3H-flumazenil) to rat cortical benzodiazepine receptors with IC50 values in the range of 0.7–13 μmol/l. The most potent compound, 2-oxo-4-phenyl-2H-pyrimido[2,1-b]- benzothiazole showed a similar potency to inhibit 3H-Ro 15-1788 binding to membrane preparations of rat brain cortex, cerebellum and hippocampus as well as to various subunit combinations of recombinant human γ-aminobutyric acidA/benzodiazepine receptors. Scatchard plot analysis showed that 2-oxo-4-phenyl-2H-pyrimido[2,1-b]benzothiazole is a competitive inhibitor of 3H-Ro 15-1788 binding to rat brain cortical membrane preparations.Keywords
This publication has 5 references indexed in Scilit:
- 6‐Methylflavone, a benzodiazepine receptor ligand with antagonistic properties on rat brain and human recombinant GABAA receptors in vitroDrug Development Research, 1997
- The rapidly expanding range of neuronal benzodiazepine receptor ligandsProgress in Neurobiology, 1993
- High affinity of the naturally-occurring biflavonoid, amentoflavon, to brain benzodiazepine receptors in vitroBiochemical Pharmacology, 1988
- 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission—II Biochemical propertiesNeuropharmacology, 1985
- 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission—INeuropharmacology, 1985